The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials.

MLA

Abdelazeem, Basel, et al. “The Effects of Curcumin as Dietary Supplement for Patients with COVID-19: A Systematic Review of Randomized Clinical Trials.” Drug Discoveries & Therapeutics, vol. 16, no. 1, 2022, pp. 14–22. EBSCOhost, https://doi.org/10.5582/ddt.2022.01017.

APA

Abdelazeem, B., Awad, A. K., Elbadawy, M. A., Manasrah, N., Malik, B., Yousaf, A., Alqasem, S., Banour, S., & Abdelmohsen, S. M. (2022). The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials. Drug Discoveries & Therapeutics, 16(1), 14–22. https://doi.org/10.5582/ddt.2022.01017

Chicago

Abdelazeem, Basel, Ahmed K Awad, Merihan A Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, Sarah Alqasem, Sandi Banour, and Sarah Magdy Abdelmohsen. 2022. “The Effects of Curcumin as Dietary Supplement for Patients with COVID-19: A Systematic Review of Randomized Clinical Trials.” Drug Discoveries & Therapeutics 16 (1): 14–22. doi:10.5582/ddt.2022.01017.